# TNT (NCT00532727)

> Triple Negative Breast Cancer Trial

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00532727
- Phase: PHASE3
- Status: UNKNOWN
- Sponsor: Institute of Cancer Research, United Kingdom
- Conditions: Breast Cancer
- Interventions: Carboplatin; Docetaxel
- Enrollment: 400
- Primary outcome: Response: Response will be evaluated after three and six cycles of chemotherapy using modified Response Evaluation Criteria in Solid Tumours (RECIST) criteria, with appropriate clinical assessment and radiological investigations.

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 10
- X threads: 10
- Podcasts: 3

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=tnt-nct00532727

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00532727", "email": "<work email>"}; the inbox owner confirms by the emailed link.